S100 Proteins
S100, S100B, S100P, S100A1, S100A2, S100A3, S100A4, S100A7, S100A8/9, S100A10, S100A11, S100A13.
Definition
S100 proteins are small molecular weight calcium-binding proteins with two calcium-binding domains made up of two helix-loop-helix (EF-hand) motifs. Also, S100 proteins are subcellular fractions of proteins which are completely (100 %) solubilized at neutral pH of saturated ammonium sulfate, hence the name S100. They are known to be highly similar in their structure and amino acid sequences but are quite different in their functions. So far, there are 21 members of the S100 family in the human genome. These proteins are often metabolized in the kidney and released in urine with a half-life of ~2 h.
Characteristics
Members of S100 protein family play a significant role in progression and metastasis of various cancers. Majority of S100 proteins are exclusively present on human chromosome 1q21, the epidermal differentiation complex (EDC) region. This region has high...
Abbreviations
- AKT:
-
Protein kinase B
- BCL2:
-
B-cell lymphoma 2
- CCL2:
-
Chemokine CC ligand 2
- CREB:
-
Camp response element-binding protein
- DLC1:
-
Deleted in liver cancer 1
- EGF:
-
Epithelial growth factor
- EMT:
-
Epithelial mesenchymal transduction
- ERK:
-
Extracellular regulated kinases
- ESCC:
-
Esophageal squamous cell carcinoma
- FGF-1:
-
Fibroblast growth factor 1
- IDC:
-
Invasive ductal carcinaoma
- Jab1:
-
c-Jun activation domain-binding protein-1
- KLF:
-
Kruppel-like factor
- miR155:
-
MicroRNA 155
- miR29b:
-
MicroRNA 29b
- MMP9:
-
Metalloproteinase 9
- MMTV:
-
Mouse mammary tumor virus.
- Ndr:
-
Nuclear Dbf2-related kinase
- NF-κB:
-
Nuclear factor-kappa B
- OSCC:
-
Oral squamous cell carcinoma
- PI3K:
-
Phosphatidylinositide 3-kinases
- PyMT:
-
Polyoma middle T-antigen
- RAGE:
-
Receptor for advanced glycation end product
- ROS:
-
Reactive oxygen species
- SP:
-
Sp transcription factor
- STAT:
-
Signal transducer and activator of transcription
- Stat3:
-
Signal transducer and activator of transcription 3
- TAMs:
-
Tyro-3 Axl, and Mer tyrosine kinase receptors
- TGF-β:
-
Transforming growth factor beta
- TLR4:
-
Toll like receptor 4
- TNF:
-
Tumor necrosis factor
- VEGF:
-
Vascular endothelial growth factor
References
Boye K, Maelandsmo GM (2010) S100A4 and metastasis: a small actor playing many roles. Am J Pathol 176(2):528–535
Bresnick AR, Weber DJ, Zimmer DB (2015) S100 proteins in cancer. Nat Rev Cancer 15(2):96–109
Chen H, Xu C, Jin Q, Liu Z (2014) S100 protein family in human cancer. Am J Cancer Res 4(2):89–115
Donato R (2001) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33(7):637–668
Drews-Elger K, Iorns E, Dias A et al (2014) Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome. Breast Cancer Res Treat 148(1):41–59
Emberley ED, Murphy LC, Watson PH (2004) S100 proteins and their influence on pro-survival pathways in cancer. Biochem Cell Biol 82(4):508–515
Foell D, Wittkowski H, Vogl T, Roth J (2007) S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 81(1):28–37
Grum-Schwensen B, Klingelhöfer J, Grigorian M et al (2010) Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors. Cancer Res 70(3):936–947
Hiratsuka S, Watanabe A, Sakurai Y et al (2008) The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol 10(11):1349–1355
Nasser MW, Qamri Z, Deol YS et al (2012) S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways. Cancer Res 72(3):604–615
Nasser MW, Wani N, Ahirwar DK et al (2015) RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment. Cancer Res 75:974
Salama I, Malone PS, Mihaimeed F, Jones JL (2008) A review of the S100 proteins in cancer. Eur J Surg Oncol 34(4):357–364
Zhao H, Wilkie T, Deol Y et al (2015) miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer. Mol Cancer 14(1):11
See Also
(2012) Astrocyte. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 297. doi:10.1007/978-3-642-16483-5_422
(2012) Bone sarcomas. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 446. doi:10.1007/978-3-642-16483-5_685
(2012) Cancer of the large intestine. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 626. doi:10.1007/978-3-642-16483-5_810
(2012) Cell cycle. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 737. doi:10.1007/978-3-642-16483-5_994
(2012) Cell cycle arrest. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 737. doi:10.1007/978-3-642-16483-5_995
(2012) Colorectal cancer. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 916. doi:10.1007/978-3-642-16483-5_1265
(2012) COX-2. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 989. doi:10.1007/978-3-642-16483-5_1355
(2012) EGF. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1211. doi:10.1007/978-3-642-16483-5_1824
(2012) ERK. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, pp 1307–1308. doi:10.1007/978-3-642-16483-5_1987
(2012) Genetically engineered mice. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1532. doi:10.1007/978-3-642-16483-5_2386
(2012) Immune system. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1815. doi:10.1007/978-3-642-16483-5_2980
(2012) Laryngeal cancer. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1981. doi:10.1007/978-3-642-16483-5_6476
(2012) Orthotopic model. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 2661. doi:10.1007/978-3-642-16483-5_4265
(2012) P53. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 2747. doi:10.1007/978-3-642-16483-5_4331
(2012) Proliferation. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3004. doi:10.1007/978-3-642-16483-5_4766
(2012) Promoter. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3004. doi:10.1007/978-3-642-16483-5_4768
(2012) Prostate cancer. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, pp 3009–3010. doi:10.1007/978-3-642-16483-5_6576
(2012) RAGE. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3163. doi:10.1007/978-3-642-16483-5_4939
(2012) SMAD. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3440. doi:10.1007/978-3-642-16483-5_5360
(2012) Sp. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3471. doi:10.1007/978-3-642-16483-5_5426
(2012) STAT. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3502. doi:10.1007/978-3-642-16483-5_5481
(2012) TNF-a. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3713. doi:10.1007/978-3-642-16483-5_5841
(2012) Tumorigenesis. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3815. doi:10.1007/978-3-642-16483-5_6063
(2012) Tumor suppressor. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3803. doi:10.1007/978-3-642-16483-5_6056
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg (outside the USA)
About this entry
Cite this entry
Elbaz, M., Amponsah, G., Ganju, R.K., Nasser, M.W. (2015). S-100 Proteins. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_5143-2
Download citation
DOI: https://doi.org/10.1007/978-3-642-27841-9_5143-2
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-27841-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences